CDIO Cardio Diagnostics Holdings, Inc. NASDAQ · United States

Cardio Diagnostics Holdings (CDIO) news

Cardio Diagnostics Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CDIO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Cardio Diagnostics Holdings news

We have not published a story on Cardio Diagnostics Holdings yet. When there is news, it will appear here.

Cardio Diagnostics Holdings annual financials

Line	FY2025	FY2024
Revenue	$14,825	$34,890
Research and development	$641,212	$227,966
Net income (loss)	-$6.5 million	-$8.4 million
Cash from operations	-$5.7 million	-$5.0 million
Cash and equivalents	$0	$0

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $0.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Cardio Diagnostics Holdings

What is the ticker symbol of Cardio Diagnostics Holdings?

Cardio Diagnostics Holdings, Inc. trades under the ticker CDIO on NASDAQ.

Where is Cardio Diagnostics Holdings listed?

Cardio Diagnostics Holdings, Inc. is listed on NASDAQ.

Which country or territory is Cardio Diagnostics Holdings listed under?

Our directory records Cardio Diagnostics Holdings, Inc. under United States.

Does aibio.space cover Cardio Diagnostics Holdings?

aibio.space lists Cardio Diagnostics Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Cardio Diagnostics Holdings's revenue last year?

$14,825 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Cardio Diagnostics Holdings profitable?

Cardio Diagnostics Holdings, Inc. reported a net loss of $6.5 million for the fiscal year ended Dec 31, 2025, and used $5.7 million of cash in operations, per its annual report to the SEC.

How much does Cardio Diagnostics Holdings spend on research and development?

$641,212 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Cardio Diagnostics Holdings have?

$0 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Cardio Diagnostics Holdings

Members talk about Cardio Diagnostics Holdings (CDIO). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:CDIO on TradingView.

Listing details

Company: Cardio Diagnostics Holdings, Inc.
Ticker: CDIO
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction